🟢 HCW Biologics is trading 7.26% up in after-hours trading with no clear company-specific catalyst identified

HCW Biologics is trading now 7.26% up at $3.40, with no clear company-specific catalyst identified for August 11, 2026.

• The latest official company release remains the July 29 private placement, which is stale and does not directly explain the move.
• Earnings-date sources conflict, but Nasdaq estimates the next report for August 17, 2026, not August 11.
• The broader market was weak, so macro sentiment does not clearly explain the gain.